Investor Presentation First Nine Months of 2022

119 Investor presentation First nine months of 2022 Obesity market share and market growth in EMEA 120% 100% 80% 60% 40% 20% 0% Obesity market growth and Novo Nordisk market share Aug 2019 NN market share -NN Growth -Market growth (right axis) Source: IQVIA, Aug 2022, Value, MAT; EMEA: Europe, Middle East and Africa; NN: Novo Nordisk DKK billion Obesity market size and growth -76% 120% 2.2 0.1 101% 100% 81% 0.9 80% 1.2 76% 60% 40% 20% 71% EMEA ~101% 81% 0% Aug Aug Aug 2022 2021 2022 Novo Nordisk Others

View entire presentation